Eusebio Gaínza
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- José Luís Pedraz (8 shared papers)Miguel Viñas (3 shared papers)Tania B. López-Méndez (2 shared papers)Rosa Marı́a Hernández (4 shared papers)Amaia Esquisabel (3 shared papers)Daniel Bachiller (4 shared papers)Ana Beloqui (1 shared paper)Yining Xu (1 shared paper)
- Journals
- International Journal of Pharmaceutics (3 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)Stem Cell Research (1 paper)Endocrine Connections (1 paper)Pharmaceutics (1 paper)
- Partner nations
- SpainSwitzerlandChina
In The Last Decade
Eusebio Gaínza
15 papers receiving 502 citations
Peers
Comparison fields: 5 of 94
- Molecular Medicine 78
- Pharmaceutical Science 82
- Applied Microbiology and Biotechnology 12
- Rehabilitation 26
- Biochemistry 21
Countries citing papers authored by Eusebio Gaínza
This map shows the geographic impact of Eusebio Gaínza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eusebio Gaínza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eusebio Gaínza more than expected).
Fields of papers citing papers by Eusebio Gaínza
This network shows the impact of papers produced by Eusebio Gaínza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eusebio Gaínza. The network helps show where Eusebio Gaínza may publish in the future.
Co-authors
The 25 scholars most cited alongside Eusebio Gaínza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 74 | |
| 2 | 2020 | 55 | |
| 3 | 2014 | 54 | |
| 4 | 2020 | 51 | |
| 5 | In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. | 2006 | 48 |
| 6 | 2013 | 41 | |
| 7 | 2019 | 40 | |
| 8 | 2020 | 36 | |
| 9 | 2020 | 34 | |
| 10 | 2019 | 25 | |
| 11 | 2020 | 17 | |
| 12 | 2019 | 10 | |
| 13 | 2018 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2019 | 4 |
About Eusebio Gaínza
Eusebio Gaínza is a scholar working on Organic Chemistry, Pharmacology, Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Medicine, having authored 15 papers that have together received 506 indexed citations. Recurring topics across this work include Fatty Acid Research and Health (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers), Wound Healing and Treatments (2 papers), Pluripotent Stem Cells Research (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Cystic Fibrosis Research Advances (2 papers) and Advanced Drug Delivery Systems (2 papers). The work is most often cited by research in Molecular Medicine (78 citations), Pharmaceutical Science (82 citations), Applied Microbiology and Biotechnology (12 citations), Rehabilitation (26 citations) and Biochemistry (21 citations). Eusebio Gaínza has collaborated with scholars based in Spain, Switzerland and China. Frequent co-authors include José Luís Pedraz, Miguel Viñas, Tania B. López-Méndez, Rosa Marı́a Hernández, Amaia Esquisabel, Daniel Bachiller, Ana Beloqui, Yining Xu, Ana Gil-Brusola and José Miguel Sahuquillo-Arce. Their work appears in journals such as International Journal of Pharmaceutics, Nanomedicine Nanotechnology Biology and Medicine, Stem Cell Research, Endocrine Connections and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.